TY - JOUR
T1 - Silent Brain Infarction and Risk of Future Stroke
T2 - A Systematic Review and Meta-Analysis
AU - Gupta, Ajay
AU - Giambrone, Ashley E.
AU - Gialdini, Gino
AU - Finn, Caitlin
AU - Delgado, Diana
AU - Gutierrez, Jose
AU - Wright, Clinton
AU - Beiser, Alexa S.
AU - Seshadri, Sudha
AU - Pandya, Ankur
AU - Kamel, Hooman
N1 - Funding Information:
We thank Drs Jukka Putaala, Toshitaka Umemura, M. Arfan Ikram, Marileen L. Portegies, Beverly G. Windham, Michael E. Griswold, and Wanmei Wang for providing both unpublished data and clarifcation of published data used in this meta-analysis.Dr Gupta reports support in part by the Foundation of the American Society of Neuroradiology Scholar Award. Dr Wright reports grants support (National Institutes of Health [NIH] NS 29993) for the Northern Manhattan Study (NOMAS). Drs Seshadri and Beiser report grant support (NIH NS017950 and AG0008122) for the Framingham Cohort Study. Dr Kamel reports grant support from the National Institute of Neurological Disorders and Stroke (K23NS082367).
Publisher Copyright:
© 2015 American Heart Association, Inc.
PY - 2016/3/1
Y1 - 2016/3/1
N2 - Background and Purpose-Silent brain infarction (SBI) on magnetic resonance imaging has been proposed as a subclinical risk marker for future symptomatic stroke. We performed a systematic review and meta-analysis to summarize the association between magnetic resonance imaging-defined SBI and future stroke risk. Methods-We searched the medical literature to identify cohort studies involving adults with SBI detected by magnetic resonance imaging who were subsequently followed up for incident clinically defined stroke. Study data and quality assessment were recorded in duplicate with disagreements in data extraction resolved by a third reader. Strength association between magnetic resonance imaging-detected SBI and future symptomatic stroke was measured by an hazard ratio. Results-The meta-analysis included 13 studies (14 764 subjects) with a mean follow-up ranging from 25.7 to 174 months. SBI predicted the occurrence of stroke with a random effects crude relative risk of 2.94 (95% confidence interval, 2.24-3.86, P<0.001; Q=39.65, P<0.001). In the 8 studies of 10 427 subjects providing hazard ratio adjusted for cardiovascular risk factors, SBI was an independent predictor of incident stroke (hazard ratio, 2.08 [95% confidence interval, 1.69-2.56; P<0.001]; Q=8.99; P=0.25). In a subgroup analysis pooling 9483 stroke-free individuals from large population-based studies, SBI was present in ≈18% of participants and remained a strong predictor of future stroke (hazard ratio, 2.06 [95% confidence interval, 1.64-2.59]; P<0.01). Conclusions-SBI is present in ≈1 in 5 stroke-free older adults and is associated with a 2-fold increased risk of future stroke. Future studies of in-depth stroke risk evaluations and intensive prevention measures are warranted in patients with clinically unrecognized radiologically evident brain infarctions.
AB - Background and Purpose-Silent brain infarction (SBI) on magnetic resonance imaging has been proposed as a subclinical risk marker for future symptomatic stroke. We performed a systematic review and meta-analysis to summarize the association between magnetic resonance imaging-defined SBI and future stroke risk. Methods-We searched the medical literature to identify cohort studies involving adults with SBI detected by magnetic resonance imaging who were subsequently followed up for incident clinically defined stroke. Study data and quality assessment were recorded in duplicate with disagreements in data extraction resolved by a third reader. Strength association between magnetic resonance imaging-detected SBI and future symptomatic stroke was measured by an hazard ratio. Results-The meta-analysis included 13 studies (14 764 subjects) with a mean follow-up ranging from 25.7 to 174 months. SBI predicted the occurrence of stroke with a random effects crude relative risk of 2.94 (95% confidence interval, 2.24-3.86, P<0.001; Q=39.65, P<0.001). In the 8 studies of 10 427 subjects providing hazard ratio adjusted for cardiovascular risk factors, SBI was an independent predictor of incident stroke (hazard ratio, 2.08 [95% confidence interval, 1.69-2.56; P<0.001]; Q=8.99; P=0.25). In a subgroup analysis pooling 9483 stroke-free individuals from large population-based studies, SBI was present in ≈18% of participants and remained a strong predictor of future stroke (hazard ratio, 2.06 [95% confidence interval, 1.64-2.59]; P<0.01). Conclusions-SBI is present in ≈1 in 5 stroke-free older adults and is associated with a 2-fold increased risk of future stroke. Future studies of in-depth stroke risk evaluations and intensive prevention measures are warranted in patients with clinically unrecognized radiologically evident brain infarctions.
KW - brain infarction
KW - infarction
KW - magnetic resonance imaging
KW - risk factors
KW - stroke
UR - http://www.scopus.com/inward/record.url?scp=84959539618&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959539618&partnerID=8YFLogxK
U2 - 10.1161/STROKEAHA.115.011889
DO - 10.1161/STROKEAHA.115.011889
M3 - Article
C2 - 26888534
AN - SCOPUS:84959539618
SN - 0039-2499
VL - 47
SP - 719
EP - 725
JO - Stroke
JF - Stroke
IS - 3
ER -